These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25585877)

  • 1. The relationship between CCR6 and its binding partners: does the CCR6-CCL20 axis have to be extended?
    Lee AY; Phan TK; Hulett MD; Körner H
    Cytokine; 2015 Mar; 72(1):97-101. PubMed ID: 25585877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR6/CCL20 chemokine axis in human immunodeficiency virus immunity and pathogenesis.
    Lee AYS; Körner H
    J Gen Virol; 2017 Mar; 98(3):338-344. PubMed ID: 28005525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20.
    Wasilko DJ; Johnson ZL; Ammirati M; Che Y; Griffor MC; Han S; Wu H
    Nat Commun; 2020 Jun; 11(1):3031. PubMed ID: 32541785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and expression analysis of two novel CCR6 chemokine receptors and their three potential ligands CCL20Ls of grouper (Epinephelus coioides) post Cryptocaryon irritans infection.
    Mo ZQ; Chen RA; Li YW; Huang XZ; Li AX; Luo XC; Dan XM
    Fish Shellfish Immunol; 2015 Nov; 47(1):280-8. PubMed ID: 26384847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells.
    Röhrl J; Yang D; Oppenheim JJ; Hehlgans T
    J Biol Chem; 2010 Mar; 285(10):7028-34. PubMed ID: 20068036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells.
    Vongsa RA; Zimmerman NP; Dwinell MB
    J Biol Chem; 2009 Apr; 284(15):10034-45. PubMed ID: 19233848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
    Frick VO; Rubie C; Keilholz U; Ghadjar P
    World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL20 and β-defensin-2 induce arrest of human Th17 cells on inflamed endothelium in vitro under flow conditions.
    Ghannam S; Dejou C; Pedretti N; Giot JP; Dorgham K; Boukhaddaoui H; Deleuze V; Bernard FX; Jorgensen C; Yssel H; Pène J
    J Immunol; 2011 Feb; 186(3):1411-20. PubMed ID: 21178014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of CCL20 reveals flexibility of N-terminal amino acid composition and length.
    Riutta SJ; Larsen O; Getschman AE; Rosenkilde MM; Hwang ST; Volkman BF
    J Leukoc Biol; 2018 Aug; 104(2):423-434. PubMed ID: 30114340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer.
    Ghadjar P; Rubie C; Aebersold DM; Keilholz U
    Int J Cancer; 2009 Aug; 125(4):741-5. PubMed ID: 19480006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-derived CCL20 affects B16 melanoma growth in mice.
    Martin-Garcia D; Silva-Vilches C; Will R; Enk AH; Lonsdorf AS
    J Dermatol Sci; 2020 Jan; 97(1):57-65. PubMed ID: 31883833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CCL20 and CCR6 axis in psoriasis.
    Furue K; Ito T; Tsuji G; Nakahara T; Furue M
    Scand J Immunol; 2020 Mar; 91(3):e12846. PubMed ID: 31692008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.
    Comerford I; Bunting M; Fenix K; Haylock-Jacobs S; Litchfield W; Harata-Lee Y; Turvey M; Brazzatti J; Gregor C; Nguyen P; Kara E; McColl SR
    Bioessays; 2010 Dec; 32(12):1067-76. PubMed ID: 20954179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice.
    Doucet M; Jayaraman S; Swenson E; Tusing B; Weber KL; Kominsky SL
    J Bone Miner Res; 2016 Jul; 31(7):1381-90. PubMed ID: 26890063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning, expression and functional characterization of chicken CCR6 and its ligand CCL20.
    Munoz I; Berges M; Bonsergent C; Cormier-Aline F; Quéré P; Sibille P
    Mol Immunol; 2009 Dec; 47(2-3):551-9. PubMed ID: 19850344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
    Lu E; Su J; Zhou Y; Zhang C; Wang Y
    Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.
    Giuliani N; Lisignoli G; Colla S; Lazzaretti M; Storti P; Mancini C; Bonomini S; Manferdini C; Codeluppi K; Facchini A; Rizzoli V
    Cancer Res; 2008 Aug; 68(16):6840-50. PubMed ID: 18703490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
    Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
    Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology.
    Lee AYS; Körner H
    Immunobiology; 2019 May; 224(3):449-454. PubMed ID: 30772094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
    Zeng W; Chang H; Ma M; Li Y
    Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.